373 related articles for article (PubMed ID: 17400844)
1. Hot flushes, bone mineral density, and fractures in older postmenopausal women.
Huang A; Grady D; Blackwell T; Bauer D
Obstet Gynecol; 2007 Apr; 109(4):841-7. PubMed ID: 17400844
[TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
[TBL] [Abstract][Full Text] [Related]
3. Persistent hot flushes in older postmenopausal women.
Huang AJ; Grady D; Jacoby VL; Blackwell TL; Bauer DC; Sawaya GF
Arch Intern Med; 2008 Apr; 168(8):840-6. PubMed ID: 18443259
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
[TBL] [Abstract][Full Text] [Related]
5. The relationship between back pain and future vertebral fracture in postmenopausal women.
Kuroda T; Shiraki M; Tanaka S; Shiraki Y; Narusawa K; Nakamura T
Spine (Phila Pa 1976); 2009 Aug; 34(18):1984-9. PubMed ID: 19680106
[TBL] [Abstract][Full Text] [Related]
6. Low bone mineral density and fracture burden in postmenopausal women.
Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk and bone density of peri- and early postmenopausal women with uterine leiomyomas.
Randell KM; Honkanen RJ; Tuppurainen MT; Kröger H; Jurvelin JS; Saarikoski S
Maturitas; 2006 Feb; 53(3):333-42. PubMed ID: 16019169
[TBL] [Abstract][Full Text] [Related]
8. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
[TBL] [Abstract][Full Text] [Related]
9. Physical activity slows femoral bone loss but promotes wrist fractures in postmenopausal women: a 15-year follow-up of the OSTPRE study.
Rikkonen T; Salovaara K; Sirola J; Kärkkäinen M; Tuppurainen M; Jurvelin J; Honkanen R; Alhava E; Kröger H
J Bone Miner Res; 2010 Nov; 25(11):2332-40. PubMed ID: 20533310
[TBL] [Abstract][Full Text] [Related]
10. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
[TBL] [Abstract][Full Text] [Related]
11. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.
Palacios S; Farias ML; Luebbert H; Gomez G; Yabur JA; Quail DC; Turbi C; Kayath MJ; Almeida MJ; Mönnig E; Nickelsen T
Am J Obstet Gynecol; 2004 Jul; 191(1):121-31. PubMed ID: 15295352
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
[TBL] [Abstract][Full Text] [Related]
15. Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group.
Ensrud KE; Cauley J; Lipschutz R; Cummings SR
Arch Intern Med; 1997 Apr; 157(8):857-63. PubMed ID: 9129545
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hot flushes and bone mineral density: a longitudinal study.
Tuomikoski P; Ylikorkala O; Mikkola TS
Acta Obstet Gynecol Scand; 2015 Feb; 94(2):198-203. PubMed ID: 25421213
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
[TBL] [Abstract][Full Text] [Related]
18. Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction.
Melton LJ; Crowson CS; O'Fallon WM; Wahner HW; Riggs BL
J Bone Miner Res; 2003 Feb; 18(2):312-8. PubMed ID: 12568408
[TBL] [Abstract][Full Text] [Related]
19. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
Kanis JA; Johansson H; Oden A; McCloskey EV
Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
[TBL] [Abstract][Full Text] [Related]
20. Hot flushes during the menopause transition: a longitudinal study in Australian-born women.
Guthrie JR; Dennerstein L; Taffe JR; Lehert P; Burger HG
Menopause; 2005; 12(4):460-7. PubMed ID: 16037762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
